01.002 RWE TNT JULY 2022 A 13-07-2022

Real-world data provides the opportunity to enhance regulatory decisions for new drugs

  • Real world data and evidence provide valuable performance data on a post-approval drug to create a comprehensive clinical snapshot
  • This can later support regulatory and reimbursement decisions and clinical guidelines
  • More and more stakeholders in the pharmaceutical pipeline are recognising the value of real-world datay
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at